![PDF) Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial. Annals of Internal Medicine, 2017; 167:476-83. PDF) Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial. Annals of Internal Medicine, 2017; 167:476-83.](https://www.researchgate.net/profile/Mark-Sanders-5/publication/320244357/figure/fig2/AS:614020700708896@1523405351897/figure-fig2_Q320.jpg)
PDF) Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial. Annals of Internal Medicine, 2017; 167:476-83.
A double-blind randomised controlled trial of Lithium Carbonate in patients with Amyotrophic Lateral Sclerosis
Overview of comments received on the guideline on core SmPC for human normal immunoglobulin for intravenous administration (IVIg
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Intratect 50 g/l, solution for infusion 2. QUALITATIVE AND
Package leaflet: Information for the user Intratect 100 g/l solution for infusion Human normal immunoglobulin (IVIg) Read all o
![Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use | SpringerLink Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F11537660-000000000-00000/MediaObjects/40259_2012_24040211_Tab1.jpg)
Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use | SpringerLink
![Table 3 from Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials | Semantic Scholar Table 3 from Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c79ae5914cc37a1c01c4ba4fa41fc894af9bebb4/4-Table3-1.png)
Table 3 from Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials | Semantic Scholar
![PDF) Safety monitoring of the intravenous immunoglobulin preparation Intratect (R) in primary and secondary immunodeficiencies: a prospective non-interventional study PDF) Safety monitoring of the intravenous immunoglobulin preparation Intratect (R) in primary and secondary immunodeficiencies: a prospective non-interventional study](https://i1.rgstatic.net/publication/267743705_Safety_monitoring_of_the_intravenous_immunoglobulin_preparation_Intratect_R_in_primary_and_secondary_immunodeficiencies_a_prospective_non-interventional_study/links/55b9e93608ae9289a09021e8/largepreview.png)
PDF) Safety monitoring of the intravenous immunoglobulin preparation Intratect (R) in primary and secondary immunodeficiencies: a prospective non-interventional study
A double-blind randomised controlled trial of Lithium Carbonate in patients with Amyotrophic Lateral Sclerosis
![PDF) Safety monitoring of the intravenous immunoglobulin preparation Intratect (R) in primary and secondary immunodeficiencies: a prospective non-interventional study PDF) Safety monitoring of the intravenous immunoglobulin preparation Intratect (R) in primary and secondary immunodeficiencies: a prospective non-interventional study](https://www.researchgate.net/profile/Artur-Bauhofer/publication/267743705/figure/tbl1/AS:613448727658531@1523268982507/Adverse-events-n_Q320.jpg)